John Brydle

John Brydle appears in our data through filings on Akseera Biosciences Incorporated shares, published by SEDI. In total, 4 filings cover trades dated from 24 November 2017 to 15 January 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 10 March 2026, reports a transaction in Akseera Biosciences Incorporated. Source: insider filings from SEDI. Past trades are no guide to future returns.